Sorrento Therapeutics Seems to Aim for a High Risk, High Reward Principle
SRNE

Sorrento Therapeutics (Ticker: SRNE) acquired SmartPharm this week for $18.6 million. The pharmaceutical company offered approximately 1.76 million shares to SmartPharm for $10.60 each. The motivation for this is to support efforts to further develop antibody treatments for COVID-19 and other diseases. Sorrento claims it has an antibody that grabs and then blocks the virus…

The R&M Only Believes In These 15 Pharmaceuticals In The Race Of The COVID-19 Vaccine

Breakout Stocks   Corona Virus Stocks The world’s largest online market research store “Research and Markets” (R&M) has officially named 15 pharmaceutical companies at the forefront of the quest for the COVID-19 vaccine. Although in some parts of the world the state of the pandemic is slowly improving, future numbers of the virus are increasing and vaccine…

Why major pharmaceutical and biotech companies will keep growing for years
GILD

Several big pharmaceutical groups are undervalued according to Morningstar: Roche ($RHHBY), Bristol ($BMY), Merck ($MRK) and Pfizer ($PFE). These stocks are expected to grow an average of 5% annually through 2024. The COVID-19 pandemic has so far not had a major negative impact on expected performance. An expected average growth till 2024 The major pharmaceutical…

Update About Moderna After Trump Tightens Targets For A COVID-19 Vaccine
MRNA

US biotech company Moderna ($MRNA) is talking with the Japanese health ministry about the supply of 40 million corona vaccines. The company confirmed this Friday afternoon after Japanese minister Kato Katsunobu communicated about this in national media. The vaccine will be supplied by Moderna, while Takeda Pharmaceutical will be responsible for distribution. The company would…